BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6662582)

  • 1. Clinical and serological evaluation of live measles vaccine in India.
    Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
    Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L
    Tr Inst Im Pastera; 1979; 53():19-25. PubMed ID: 262709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serological methods of detecting antibodies against the measles virus: use of the ELISA immunoenzyme technic].
    Rapicetta M; Proietti E; Morace G; Rozera C; Macchia T
    Ann Ist Super Sanita; 1982; 18(3):525-8. PubMed ID: 7187839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Persistence of immunity to attenuated measles live vaccine. VI. Observation on the results of revaccination with different vaccines via varied routes].
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):541-5. PubMed ID: 6418355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 8. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Persistence of immunity to attenuated measles live vaccine. V. Persistence of immunity after primary immunization with 4 strains of live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):490-2. PubMed ID: 6418341
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.
    Kovarik J; Gaillard M; Martinez X; Bozzotti P; Lambert PH; Wild TF; Siegrist CA
    Virology; 2001 Jun; 285(1):12-20. PubMed ID: 11414801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measles: notes on epidemiology and prevention, including the military community].
    Zardi O
    Riv Med Aeronaut Spaz; 1979; 42(1-2):124-60. PubMed ID: 400041
    [No Abstract]   [Full Text] [Related]  

  • 13. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature.
    Uzicanin A; Zimmerman L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S133-48. PubMed ID: 21666154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological examination in measles].
    Janout V
    Cesk Epidemiol Mikrobiol Imunol; 1979 Apr; 28(3):144-50. PubMed ID: 158438
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles immunization: new recommendation.
    Krugman S
    JAMA; 1977 Jan; 237(4):366. PubMed ID: 576171
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of observing the immunity dynamics in those inoculated with live Leningrad-16 and Schwartz measles vaccines].
    Zetilova LP; Bolotovskiĭ VM; Trufanova II; Abzalov KA; Duramshina NS
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):95-8. PubMed ID: 4281242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.